Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2026
Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in gliomaBrittney Lozzi, Taylor A Gatesman, Pushan Dasgupta, et al.
American Journal of Cancer Research|October 18, 2021
Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumorsHaiping Jiang, Ning Li, Huan Wang, et al.
Oncogene|June 15, 2020
Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMTHongyang Yi, Guipeng Li, Yongkang Long, et al.
Annals of Translational Medicine|June 24, 2021
Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world studyJun Ma, Huiqiang Huang, Peifen Fu, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Efficacy and safety of anti-LAG-3 IBI110 in combination with sintilimab and chemotherapy for advanced squamous non-small cell lung cancer: a randomized phase II studyQianyi Wang, Anwen Xiong, Chenyu Mao, et al.
Immunity, Inflammation and Disease|August 6, 2024
A multicenter, prospective, non-interventional real-world study to assess the effectiveness of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal cancerChenyu Mao, Ye He, Nong Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2019
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II TrialJianming Xu, Jie Li, Chunmei Bai, et al.
BMC Cancer|April 21, 2025
Mecapegfilgrastim prophylaxis for neutropenia in patients with non-myeloid malignancies: A Chinese nationwide real-world studyShukui Qin, Yanxia Shi, Peifen Fu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 4, 2021
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumorsYingying Xu, Yakun Wang, Jifang Gong, et al.
Pageof 5